Your browser doesn't support javascript.
loading
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
Kamal, Maud; Lameiras, Sonia; Deloger, Marc; Morel, Adeline; Vacher, Sophie; Lecerf, Charlotte; Dupain, Célia; Jeannot, Emmanuelle; Girard, Elodie; Baulande, Sylvain; Dubot, Coraline; Kenter, Gemma; Jordanova, Ekaterina S; Berns, Els M J J; Bataillon, Guillaume; Popovic, Marina; Rouzier, Roman; Cacheux, Wulfran; Le Tourneau, Christophe; Nicolas, Alain; Servant, Nicolas; Scholl, Suzy M; Bièche, Ivan.
Afiliação
  • Kamal M; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France. maud.kamal@curie.fr.
  • Lameiras S; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 92210, Saint-Cloud, France. maud.kamal@curie.fr.
  • Deloger M; Institut Curie, Genomics of Excellence (ICGex) Platform, PSL Research University, 75005, Paris, France.
  • Morel A; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.
  • Vacher S; Department of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.
  • Lecerf C; Department of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.
  • Dupain C; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
  • Jeannot E; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 92210, Saint-Cloud, France.
  • Girard E; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
  • Baulande S; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 92210, Saint-Cloud, France.
  • Dubot C; Department of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.
  • Kenter G; Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France.
  • Jordanova ES; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.
  • Berns EMJJ; Institut Curie, Genomics of Excellence (ICGex) Platform, PSL Research University, 75005, Paris, France.
  • Bataillon G; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
  • Popovic M; Department of Drug Development and Innovation, Institut Curie, PSL Research University, 92210, Saint-Cloud, France.
  • Rouzier R; Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Cacheux W; Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Le Tourneau C; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Nicolas A; Department of Medical Oncology, Erasmus MC, 3000 CA, Rotterdam, The Netherlands.
  • Servant N; Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France.
  • Scholl SM; Oncology Institute of Vojvodina, Put doktora Goldmana, 421204, Sremska Kamenica, Serbia.
  • Bièche I; Department of Surgery, Institut Curie, PSL Research University, 92210, Saint-Cloud, France.
Br J Cancer ; 128(9): 1790, 2023 May.
Article em En | MEDLINE | ID: mdl-37055522
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article